Investigations of the pathogenic factors active during chronic B cell activation in SS have focused on several molecules, such as B cell activating factor (BAFF), β2 microglobulin (β2M), and serum-free light chains [3,55,56]. Here, TNFSF13B is linked to synovial sarcoma.